nsc-172755 has been researched along with Adverse Drug Event in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Allabi, ACE; Hounkponou, M; Quenum, R; Tchabi, Y; Vehounkpe-Sacca, J | 1 |
Afangnihoun, A; Atadokpede, F; Cot, M; Denoeud-Ndam, L; Dossou-Gbete, L; Fourcade, C; Girard, PM; Komongui, DG; Ndam, NT; Porcher, R; Taron-Brocard, C; Zannou, DM | 1 |
Afangnihoun, A; Agossou, VK; Akakpo, J; Atadokpédé, F; Briand, V; Clément, MC; Cot, M; Denoeud-Ndam, L; Dossou-Gbété, L; Girard, PM; Komongui, DG; Zannou, DM | 1 |
2 trial(s) available for nsc-172755 and Adverse Drug Event
Article | Year |
---|---|
Cotrimoxazole prophylaxis versus mefloquine intermittent preventive treatment to prevent malaria in HIV-infected pregnant women: two randomized controlled trials.
Topics: Adult; Antimalarials; Benin; Chemoprevention; Dizziness; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; Humans; Infant; Infant, Newborn; Malaria; Mefloquine; Parasitemia; Pregnancy; Pregnancy Complications, Parasitic; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2014 |
Tolerability of mefloquine intermittent preventive treatment for malaria in HIV-infected pregnant women in Benin.
Topics: Adult; Antimalarials; Benin; Chemoprevention; Cohort Studies; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; Humans; Malaria; Mefloquine; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies | 2012 |
1 other study(ies) available for nsc-172755 and Adverse Drug Event
Article | Year |
---|---|
A Prospective Analysis of Potential and Observed Drug-Drug Interactions, Adverse Events and its Associated Risk Factors in Hospitalized Cardiology Patients in Benin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benin; Cardiovascular Diseases; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Female; Hospitalization; Humans; Male; Middle Aged; Prevalence; Prospective Studies; Risk Factors; Young Adult | 2020 |